The mammalian lung develops from an endodermal tube, derived from an invagination of the primitive foregut, entering the splanchnic mesoderm. This embryonic stage is followed by the pseudoglandular stage of sequential tubular bifurcations. In the subsequent canalicular stage, there is vascularization of the developing lung, which is followed by the saccular stage of acinar development (1). Because lung organogenesis involves cell proliferation, migration, and differentiation, the ontogenic sequence of these events in lung momhonenesis needs to be well coordi---
The mammalian lung develops from an endodermal tube, derived from an invagination of the primitive foregut, entering the splanchnic mesoderm. This embryonic stage is followed by the pseudoglandular stage of sequential tubular bifurcations. In the subsequent canalicular stage, there is vascularization of the developing lung, which is followed by the saccular stage of acinar development (1). Because lung organogenesis involves cell proliferation, migration, and differentiation, the ontogenic sequence of these events in lung momhonenesis needs to be well coordi---nated. Polypeptide growth factors are believed to play a vital role in a number of these cellular processes, including cell prolifera-5). Transforming growth factor-pi, which may modulate extracellular matrix composition, also appears to play a role in lung branching morphogenesis (6) .
PDGF, a known mitogen for cells of mesenchymal origin, consists of two peptide chains, denoted A and B, which can be dimerized (7) in various active isoforms (PDGF-AA, -AB, -BB). The three isoforms differ in their functional properties as well as in their secretory behavior (8) . Both the A-chain and B-chain precursors contain signal sequences that allow PDGF-AA and PDGF-AB to be rapidly secreted from their producer cell. A 24-kD form of PDGF-BB remains, to a large extent, associated with the producer cell, and relatively small amounts of 30-kD PDGF-BB are secreted (9, 10) . Binding of the PDGF ligand to highaffinity cell surface receptors elicits a cascade of intracellular changes that lead to DNA synthesis and cell proliferation. PDGF receptors have been found on most mesenchymal connective tissue-forming cells, including fibroblasts, osteoblasts, chrondroblasts, smooth muscle cells, glial cells, and microvascular (capillary) endothelial cells. Although initial studies of the PDGF molecule suggested that it was primarily a mitogen for connective tissue-derived cells, recent findings have shown that it may induce growth of some epithelial cells (1 1, 13). In addition, PDGF receptors have been reported to be present on mammary, skin (1 I), and olfactory (12) epithelial cells.
In a recent study, we reported gestation-dependent changes in PDGF-A and PDGF-B transcripts during late fetal rat lung development (14) . The ontogenic pattern of PDGF gene expression was similar to that of the cell cycle-related genes DNA polymerase a and histone 3, with a marked increase of expression during the canalicular stage of lung maturation followed by a decrease during the saccular stage. These findings are compatible with a role for PDGF molecules in lung cell proliferation during late stages of rat lung development. Inasmuch as we have previously observed that both microvascular endothelial cells (15) and epithelial cells (16) purified from fetal rat lung will divide in response to PDGF, it was of interest to determine if PDGF was localized to these cell types in vivo and to determine their ontogeny using Western blot immunoanalysis. The cellular localization and content of PDGF molecules in the developing lung has not, to our knowledge, been previously reported.
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Wistar rats were originally obtained from Charles River (St. Constant, Quebec, Canada), and were maintained as a breeding colony within our animal services facilities. Pregnant dams carrying fetuses of known gestational age were killed by exposure to an excess of ether. The uterus was exposed, and the embryos and fetuses were delivered. Whole embryos were studied on d 12 of gestation, and the lungs were removed for study from 13 to 22 d gestation (term = 22 d).
Immunohistochemistry of PDGF-AA and PDGF-BB. Tissues for cryosection were fixed as described by Simmons et al. (17) . Sections (5 pm) were cut on a cryotome and mounted on aaminopropyltriethoxysilane-coated slides. The avidin-biotin immunoperoxidase method (1 8) was used to study the immunolocalization of PDGF-AA and PDGF-BB in rat fetal lungs. Embedding medium from the cryosections was dissolved in PBS. Endogenous peroxidases were quenched in 1 % (vol/vol) hydrogen peroxide in methanol for 30 min. Nonspecific binding sites were blocked by using 5 % (vol/vol) NGS and 1 % (wt/vol) BSA in PBS for 30 min. The excess of blocking solution was carefully blotted at the edges of the tissue sections and the sections were incubated overnight at 4°C with 1:300 dilutions of rabbit antihuman PDGF-AA or PDGF-BB. Subsequent procedures were conducted at room temperature. The tissue sections were washed three times in PBS, then incubated with a 1:200 dilution of biotinylated secondary goat anti-rabbit IgG for 2 h. After they were washed an additional three times in PBS, the tissue sections were incubated with an avidin-biotin complex for 1 h. Slides were washed again in PBS and developed in 0.075% (wt/vol) 3,3'-diaminobenzidine in Tris-HC1 buffer, pH 7.6, containing 0.002% (vol/vol) hydrogen peroxide. Tissue sections were lightly counterstained with Carazzi's hematoxylin, dehydrated in an ascending ethanol series then xylene, and mounted. Dot-blot immunoanalysis showed the absence of any PDGF reactive molecules in NGS, and deletion of NGS from the blocking solution did not affect the PDGF immunostaining pattern. In control experiments, anti-PDGF IgG was replaced with preimmune or nonimmune rat or rabbit sera, or with blocking solution (5% NGS and 1 % BSA). No immunostaining was observed under these conditions. Immunoabsorption studies, which were conducted by incubating the primary antibodies with excess human recombinant PDGF-A and PDGF-B homodimers for 2 h, also resulted in an absence of immunostaining.
Western blot immunoanalysis. Embryonic and fetal lungs from d 14 to 22 of gestation were dissected and placed briefly in icecold PBS. They were then homogenized in a Dounce (Vineland, NJ) homogenizer with five volumes of lysis buffer containing 10 mM Tris, 140 mM sodium chloride, 1 % (vol/vol) Triton-X 100, 0.1 % (wt/vol) SDS, and 1 mM phenylmethylsulfonyl fluoride. The homogenates were left on ice for 4 h before centrifugation at 10 000 x g for 10 min. Protein content was estimated according to Bradford (19) . Aliquots from lung homogenates of each gestational age, containing 300 pg of protein, were diluted with sample buffers and separated by gel electrophoresis as described by Laemmli (20) . Unreduced conditions and 10% (wt/ vol) polyacrylamide gels were used for studies of PDGF-AA and PDGF-BB. Proteins were electrophoretically transferred from the polyacrylamide gels to nitrocellulose membranes (2 1). Nons~ecific binding was blocked by incubation with 5% NGS and I% BSA (PDGF-AA and -BB) in TBS for 1 h at room temperature while the samples were shaken, followed by an overnight incubation with antibodies diluted 1:200. The membranes were incubated with 1:4000 goat anti-rabbit IgG for 2 h, followed by 1 : 1000 rabbit PAP soluble complex for 30 min. The membranes were thoroughly washed with cold TBS (three times for 10 min) between each incubation step. The peroxidase reaction was developed using 0.03% (vol/vol) hydrogen peroxide, 0.1 % (wt/vol) diaminobenzidine tetrahydrochloride, 0.075% (wt/vol) cobalt chloride in TBS, pH 7.8.
Immunoreactivity of PDGF-AA and PDGF-BB. The lung bud from whole embryo sections of 12 d gestation showed positive immunoreactivity to PDGF-BB in the epithelial lining of the primitive airway, but not in the surrounding mesenchyme (Fig.  16) . Positive immunoreactivity to PDGF-AA was also observed in ependymal and mantle layers of the developing brain vesicles, which develop into neurons and some glial cells in later stages of development (Fig. la) . This finding is consistent with previous studies that demonstrated PDGF-A and PDGF-B expression in neurons (22, 23) . The lung at 13 d gestation showed a distribution of immunoreactivity similar to that seen in the lung bud at 12 d gestation (Fig. l c and d) . A few mesenchymal cells with positive immunoreactivity to both PDGF were first noted in the lung at 14-15 d gestation (Fig. 1 e and f ) . (Fig. 2e andf) . Areas of intense immunoreactivity to both PDGF were again observed in the fetal lung at 20 d gestation, with a significant increase in the number of immunoreactive epithelial cells lining the large airways (Fig. 3c ) and distal respiratory tubules and the number of immunoreactive interstitial cells (Fig. 3a, b, and d) . In addition, positive immunoreactivity to both PDGF was seen in chondrocytes of the tracheal rings and in smooth muscle cells surrounding blood vessels (Fig. 3a  and b ) and large airways. Endothelial cells lining large vessels did not express either form of PDGF during fetal lung development ( Fig. 2c and d) . Expression of PDGF-AA and PDGF-BB during the saccular stage of lung development (2 1 and 22 d of gestation) was quite distinct from that observed in the late canalicular stage at 20 d gestation. Weakly positive immunoreactivity to PDGF-AA and PDGF-BB was observed in smooth muscle cells surrounding the airways and large vessels and in a few macrophages, with no immunoreactivity of epithelial cells in the saccular region (Fig. 3e andf) .
Mesothelial cells of embryonic lung at 12 and 13 d gestation showed no PDGF immunoreactivity. A few mesothelial cells showing immunoreactivity to both PDGF were seen in the fetal lung at 14 d gestation, after which there was a progressive increase in immunoreactive cells from 15 ( Fig. 1 e andf) Western blot irnmunoanalyses. Single protein bands were detected at 32 kD with antibody to PDGF-AA and at 28 kD with antibody to PDGF-BB, consistent with the reported molecular mass for PDGF dimers (7). Both PDGF-AA and PDGF-BB protein levels were high during the pseudoglandular period (d 14-17) of rat lung development (Figs. 4 and 5) . The protein content of PDGF-AA declined from d 18 gestation onward and was barely detectable during the saccular stage (d 21-22) of development (Fig. 4) . PDGF-BB expression also declined from d 18 gestation to term (Fig. 5) .
DISCUSSION
The present study localized both PDGF-AA and PDGF-BB in airway epithelial cells as well as in mesenchymal cells of developing rat lung. Immunoreactivity to both dimeric forms of PDGF was detected in airway epithelial cells as early as d 12 of gestation in the embryonic lung, 2 d before the appearance of immunoreactivity in mesenchymal cells. PDGF-AA and PDGF-BB immunoreactivity was detected in mesenchymal cells from d 14 of gestation onward, whereas immunoreactivity to both there is a relative increase in the proportion of epithelial cells, ring during the late canalicular stage of fetal lung development. compared with other cell types, at this stage of fetal rat lung The substantial reduction in lung PDGF-AA and PDGF-BB development. Taken together, these findings are compatible with immunoreactivity evident on d 21 and 22 of gestation suggests a role for both forms of PDGF in the proliferative events occur-that PDGF are less important during the saccular stage of lung rSl ----.--development, when alveolar precursors are formed. Only smooth muscle cells of the large airways and vessels had weak PDGF reactivity during the saccular stage. Relative changes in PDGF-AA and PDGF-BB expression during the later stages of fetal lung development may occur because of regulation of PDGF peptide synthesis at the level of transcription or by altered rates of growth factor inactivation. There is a good correlation between these immunocytochemical studies and our previous observation that PDGF-A and PDGF-B mRNA levels increase markedly during the late canalicular stage of lung development but decline during the saccular stage (14) . Together, these findings suggest that the observed decrease in PDGF immunoreactivity during the sac-32 kDa cular stage of lung development is a pretranslational event.
Western blot immunoanalyses of whole lung homogenates confirmed gestation-dependent changes in protein levels of both PDGF content. ex~ressed in this wav. remained relativelv constant during development, and a sli&t increase was not& at d -.. - 
20.
These studies demonstrate the localization of PDGF-AA and PDGF-BB to airway epithelial cells, as well as to mesenchymal cells, but do not allow us to identify the source of PDGF production, which will require in situ hybridization studies. These findings are consistent with our previous in vivo (14) and in vitro (26) observations, which suggest that fetal lung produces PDGF molecules that are involved in both epithelial and mesenchymal cell growth. Overall, these studies support a role for PDGF in airway epithelial cell proliferation during fetal lung development.
